1-5 of 5
Malgorzata Trawinska
Close
Sort by
Journal Articles

Efficacy and Safety of Ruxolitinib in Elderly Patients (> 75 years) with Myelofibrosis

Roberto Latagliata, MD, Ambra Di Veroli, MD, Giuseppe Alberto Palumbo, MD, Massimiliano Bonifacio, Alessandro Andriani, MD, Nicola Polverelli, MD PhD student, Malgorzata Trawinska, MD, Mario Tiribelli, MD, Barbara Anaclerico, MD, Giulia Benevolo, MD, Luca Petriccione, MD, Bruno Martino, MD, Antonia Centra, MD, Mariella D'Adda, MD, Monica Crugnola, MD, Francesco Cavazzini, MD, Micaela Bergamaschi, MD, Alessia Tieghi, MD, Adalberto Ibatici, MD, Costanza Bosi, MD, Margherita Perricone, PhD, Marco Montanaro, MD, Michele Cavo, Massimo Breccia, MD, Nicola Vianelli, MD, Francesca Palandri, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4251.
https://doi.org/10.1182/blood.V128.22.4251.4251
Published: 2016
Journal Articles

Incidence of Early Thrombosis in Myeloproliferative Neoplasms (MPN): A Prospective Analysis from the Gruppo Laziale of Ph-Negative MPN

Ambra Di Veroli, MD, Marianna De Muro, MD, Alessandro Andriani, MD, Malgorzata Trawinska, MD, Elena Rossi, MD, Cristina Santoro, MD, Sabrina Crescenzi Leonetti, MD, Cinzia De Gregoris, Atelda Romano, MD, Luca Petriccione, MD, Ada D'Addosio, MD, Antonia Centra, MD, Annamaria Rauco, MD, Nicoletta Villivà, Barbara Anaclerico, MD, Elisabetta Abruzzese, MD, Massimo Breccia, MD, Luca Maurillo, MD, Giuliana Alimena, Roberto Ricci, Dr., Valerio De Stefano, MD, Marco Montanaro, MD, Roberto Latagliata, MD
Journal: Blood
Blood (2016) 128 (22): 1951.
https://doi.org/10.1182/blood.V128.22.1951.1951
Published: 2016
Journal Articles

Deferasirox in the Treatment of Iron Overload during Myeloproliferative Neoplasms (MPN)

Raffaele Porrini, MD, Alessia Campagna, MD, Marianna De Muro, MD, Malgorzata Trawinska, MD, Ambra Di Veroli, MD, Sabrina Leonetti Crescenzi, MD, Luca Petruccione, MD, Atelda Romano, MD, Ada D'Addosio, MD, Angela Rago, MD, Marco Montanaro, MD, Alessandro Andriani, MD, Pasquale Niscola, MD, Enrico Montefusco, Massimo Breccia, MD, Giuliana Alimena, Roberto Latagliata, MD, Agostino Tafuri, MD
Journal: Blood
Blood (2016) 128 (22): 5465.
https://doi.org/10.1182/blood.V128.22.5465.5465
Published: 2016
Journal Articles

Retrospective Application of European LeukemiaNet Provisional Criteria for Second-Generation TKI Chronic Myeloid Leukemia

Massimo Breccia, Roberto Latagliata, MD, Fabio Stagno, Antonella Gozzini, Elisabetta Abruzzese, Francesco Albano, Vincenzo Federico, Federica Sorà, Paolo Vigneri, Giuseppina Loglisci, Malgorzata Trawinska, Simona Sica, Giorgina Specchia, Valeria Santini, MD, Giuliana Alimena
Journal: Blood
Blood (2010) 116 (21): 2270.
https://doi.org/10.1182/blood.V116.21.2270.2270
Published: 2010
Journal Articles

Hammersmith Score Is Able to Identify Chronic Myeloid Leukemia Patients with Poor Prognosis Before Treatment with Second-Generation TKIs.

Massimo Breccia, Roberto Latagliata, MD, Fabio Stagno, Antonella Gozzini, Elisabetta Abruzzese, Antonella Russo Rossi, Michelina Santopietro, Laura Cannella, Federica Sorà, Paolo Vigneri, Malgorzata Trawinska, Simona Sica, Giorgina Specchia, Valeria Santini, MD, Giuliana Alimena
Journal: Blood
Blood (2010) 116 (21): 3409.
https://doi.org/10.1182/blood.V116.21.3409.3409
Published: 2010